Novartis AG is 153.0x more valuable than Nurix Therapeutics, Inc. by market capitalization ($283.13 B vs $1.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NRIX | NVS |
|---|---|---|
| Market cap | $1.85 B | $283.13 B |
| US-listed rank | #2152 | #47 |
| Revenue (latest FY) | $83.98M | - |
| Net income (latest FY) | -$264.46M | - |
| Net margin | -314.9% | - |
| SEC filings | 511 | 947 |
Novartis AG is 153.0x more valuable than Nurix Therapeutics, Inc. by market capitalization ($283.13 B vs $1.85 B).
Full pages: Nurix Therapeutics, Inc. and Novartis AG, or browse the full rankings.